Results 211 to 220 of about 35,095 (251)

Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

open access: yesPediatric Blood &Cancer, Volume 72, Issue 4, April 2025.
ABSTRACT Background Systemic inflammatory diseases (SIDs) have been reported in patients with sickle cell disease (SCD), but clinical data in children are scarce. Objectives To identify clinical and laboratory features at diagnosis of SID in children with SCD and to describe their evolution.
Caroline Vinit   +19 more
wiley   +1 more source

Acute Rheumatic Fever in Children: The Known and the Unknown Among Saudi Mothers in the Jazan Region. [PDF]

open access: yesCureus
Eltyeb EE   +8 more
europepmc   +1 more source

Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction. [PDF]

open access: yesPLoS One, 2021
da Silva TL   +6 more
europepmc   +1 more source

Mitral stenosis acute pulmonary edema and rheumatic fever pneumonitis [PDF]

open access: bronze, 2011
Paulo Roberto Barbosa Évora   +3 more
openalex   +1 more source

Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 2, April 2025.
ABSTRACT Interstitial lung disease (ILD) is a clinically relevant adverse event associated with biologic agent use. However, the current incidence of ILD remains unclear as large‐scale risk assessments of biologic agents have not been conducted. The aim of this study was to clarify the association between biologic agent use and ILD development in ...
Ayu Minagi   +7 more
wiley   +1 more source

From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 2, April 2025.
ABSTRACT The recent review of a new drug application for MDMA‐assisted therapy for posttraumatic stress disorder by the United States' Food and Drug Administration (FDA) highlighted epistemological and methodological challenges for evidence assessments.
Eduardo Ekman Schenberg
wiley   +1 more source

Home - About - Disclaimer - Privacy